| Literature DB >> 34746493 |
Suhani Dalal1, Ahish Chitneni1, Amnon A Berger2, Vwaire Orhurhu3, Bilal Dar4, Bennett Kramer5, Anvinh Nguyen6, John Pruit6, Charles Halsted6, Alan D Kaye7, Jamal Hasoon8.
Abstract
With the ongoing public health crisis with prescription opioids, there is a need for safer alternatives for medication management in chronic pain patients. Buprenorphine is a partial mu-opioid agonist which is commonly utilized to treat patients with opioid-use disorders. The purpose of this review is to discuss the potential use of this medication for the treatment of chronic pain instead of resorting to more traditional Schedule II opioids. Buprenorphine offers a safer alternative for patients who require opioids to manage chronic pain, given the unique pharmacological properties that allow it to provide adequate analgesia with less abuse potential.Entities:
Keywords: analgesics; buprenorphine; chronic pain; opioids
Year: 2021 PMID: 34746493 PMCID: PMC8567798 DOI: 10.52965/001c.27241
Source DB: PubMed Journal: Health Psychol Res ISSN: 2420-8124